Psychedelics


Numinus announces Clinical Advisory Council to advance integrated wellness model

June 24th, 2020 - Ryan Allway

Canada NewsWire VANCOUVER, BC, June 24, 2020 Advisors including Dr. Gabor Maté and Zach Walsh bring training and expertise in psychedelic-assisted therapy and mental health treatment VANCOUVER, BC, June 24, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus”) (TSX-V: NUMI) is pleased to announce its Clinical Advisory Council, chaired by Numinus Chief Medical Officer Dr. Evan Wood. Leveraging the expertise of its members, […]

New Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory Board

June 22nd, 2020 - Ryan Allway

NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave Holdings“) (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), is an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce that it has brought on Dr. Dennis McKenna, Ph.D. to its Psychedelic Research Advisory Board (“Advisory Board”). Dr. Dennis McKenna is an internationally […]

New Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical Development

June 22nd, 2020 - Ryan Allway

NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave“) (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce that it has welcomed Dr. Carolyn Myers, Ph.D. to provide business strategy and business development consulting services to the Company. Dr. Carolyn Myers is an […]

Champignon Announces Regulatory Review

June 22nd, 2020 - Ryan Allway

VANCOUVER, British Columbia, June 22, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) announces that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”). The review relates to the Company’s disclosure obligations since it became a reporting issuer […]

Newton Energy Corporation Announces Letter of Intent with Field Trip Psychedelics Inc.

June 22nd, 2020 - Ryan Allway

Newton Energy Corporation (“Newton”) (TSXV: NTN.H) is pleased to announce that it has entered into a letter of intent dated June 18, 2020 with Field Trip Psychedelics Inc. (www.fieldtriphealth.com) (“Field Trip”) to complete a going-public transaction in Canada for Field Trip (the “Proposed Transaction”). For convenience, Newton, as it will exist after completion of the […]

Yukoterre Resources Announces Proposed Reverse Takeover by Psychdelics Company Silo Wellness

June 18th, 2020 - Ryan Allway

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 17, 2020 (GLOBE NEWSWIRE) — YUKOTERRE RESOURCES INC. (“Yukoterre”) (CSE:YT), is pleased to announce that it has entered into a binding letter of intent (the “LOI”) with FlyOverture Equity Inc., operating as Silo Wellness (“SILO”), dated June 16, […]

MindMed To Evaluate Ayahuasca’s Active Ingredient DMT In Phase 1 Clinical Trial Collaboration

June 18th, 2020 - Ryan Allway

Phase 1 Trial to experiment with dosing methods to better understand how humans react to DMT, setting stage for future potential Phase 2a proof of concept trials BASEL, Switzerland, June 18, 2020 /PRNewswire/ — MindMed will now pursue N,N-Dimethyltryptamine (DMT), the principally active ingredient in Ayahuasca, as part of its R&D collaboration with the University […]

NeonMind Files Patent Application for Therapeutic Use of DMT

June 18th, 2020 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – June 18, 2020) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces that its majority owned subsidiary NeonMind has filed an additional provisional patent application related to using psychedelics as medicine. The most recent patent application, filed on June 17, 2020 covers the administration of DMT to […]

Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth Platform

June 17th, 2020 - Ryan Allway

VANCOUVER, British Columbia, June 17, 2020 /CNW/ — Mydecine Innovations Group Inc. (formerly New Leaf Brands Inc.) (CNSX: MYCO) (OTCMKTS: MYCOF) (FSE: 0NF) (“Mydecine” or the “Company”) is pleased to announce that it has signed a definitive share exchange agreement with Mindleap Health Inc. (“Mindleap”) for the acquisition of a 100% interest in MindLeap’s Digital […]

Red Light Holland Announces Closing of Second Tranche of Private Placement

June 16th, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – June 16, 2020) – Red Light Holland Corp. (CSE:TRIP) (“Red Light Holland” or the “Company“) , an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has […]

Pharmadrug Inc. Completes Acquisition of Super Smart with a New Added Focus on the Psychedelic Market

June 15th, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – June 15, 2020) – Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (“Pharmadrug”) is pleased to announce that it has completed its previously announced (see press release dated May 25, 2020) acquisition of all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing business as Super Smart). (“Super Smart”). The acquisition […]

MDLink Fast-Tracking Its Telemedicine Platform to Meet the Demand In The Caribbean Countries with an Influx of 400% in Participating Doctors

June 15th, 2020 - Ryan Allway

Ehave, Inc. Subsidiary MDLink growing at a tremendous pace opening opportunities for platform MIAMI, Fla., June 15, 2020 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today its Jamaican based MDLink subsidiary is fast-tracking the development of digital solutions to meet […]

Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out

June 15th, 2020 - Ryan Allway

VANCOUVER, British Columbia, June 15, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, since commencing trading on March 2, 2020 has expanded its initiatives and rapidly executed on such initiatives to position the Company […]

Red Light Holland Announces Listing on Frankfurt Stock Exchange

June 11th, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – June 11, 2020) – Red Light Holland Corp. (CSE: TRIP) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce the listing of […]

Red Light Holland Closes $3M First Tranche of Private Placement

June 9th, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – June 9, 2020) – Red Light Holland Corp. (CSE: TRIP) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has […]

Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

June 8th, 2020 - Ryan Allway

Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is pleased to announce it has selected Toronto-based Dalriada Drug Discovery Inc. (“Dalriada”) to advance its new chemical entity (“NCE”) IP portfolio as it pertains to ketamine and psilocybin/psilicin […]

Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line

June 4th, 2020 - Ryan Allway

VANCOUVER, BC, June 4, 2020 /PRNewswire/ – Hollister Biosciences Inc. (CSE: HOLL) (OTCPINK: HSTRF) (Frankfurt: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that the Company’s 100% owned subsidiary, AlphaMind Brands Inc. (“AlphaMind”) plans to launch medicinal mushroom based capsule and powder product lines. The […]

MindMed Launches Project Lucy Focused on LSD Experiential Therapy For Anxiety Disorders

June 4th, 2020 - Ryan Allway

Canada NewsWire NEW YORK, June 4, 2020 Targeting a Phase 2b psychedelic assisted therapy trial for the treatment of anxiety disorders NEW YORK, June 4, 2020 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, has officially launched Project Lucy, a commercial drug development program for the treatment of anxiety disorders. […]

NeonMind Files for U.S. Provisional Patent to Use Psychedelic-Assisted Psychotherapy for Weight Loss

June 4th, 2020 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – June 4, 2020) –  The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces that its majority owned subsidiary NeonMind, on June 3, 2020 filed a U.S. provisional patent application in the United States for the invention relating to therapeutic administration of psilocybin or psilocin (or analogs thereof) (“Psilocybin“) combined […]

Pharmadrug Appoints Cannabis Icon Terry Booth as Chairman of Advisory Board

June 3rd, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – June 2, 2020) – PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the “Company” or “PharmaDrug“) is pleased to announce that it has appointed global cannabis industry pioneer and founder of Aurora Cannabis Inc. (NYSE: ACB) (“Aurora“), Terry Booth, as the Chairman of its advisory board focussing on the Company’s psychedelic business. Mr. Booth has […]

Red Light Holland Appoints Prominent Real Estate Developer, Brad J. Lamb, as Chairman of the Board of Directors and Provides Corporate Update

June 2nd, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – June 2, 2020) – Red Light Holland Corp. (CSE:TRIP) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce the appointment of Mr. […]

MindMed’s Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSD For Adult ADHD

June 2nd, 2020 - Ryan Allway

Adds Clinical Trial Site at University Hospital Basel and Appoints World Leading Psychedelics Researcher Dr. Matthias Liechti as Principal Investigator View the official release BASEL, Switzerland, June 2, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF) is expanding its Phase 2a clinical trial of LSD microdosing for Adult ADHD. MindMed is the […]

Ehave, Inc. To Acquire Mdlink The Largest Telemedicine Platform in The CARICOM Countries And To Launch Mdlink Mental Therapy along with Psychedelic Treatments To Address Mental Health

June 2nd, 2020 - Ryan Allway

haveEhave enters lucrative Market Slated to Grow from $34.28 billion in 2018 $185.66 billion by 2026 MIAMI, Fla., June 02, 2020 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today it has signed a letter of intent to acquire 51% of […]

NewLeaf Brands Announces Name and Stock Ticker Symbol Change to Mydecine Innovations Group Inc. (CSE: MYCO)

June 1st, 2020 - Ryan Allway

VANCOUVER, British Columbia, June 1, 2020 /CNW/ — NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company“) is pleased to announce that it has changed its name from NewLeaf Brands Inc. to Mydecine Innovations Group Inc. and its ticker symbol from ‘NLB’ to ‘MYCO’. Subject to approval of the Canadian Securities Exchange (the “CSE”), the […]

Pharmadrug Inc. Unveils Roadmap for European Psilocybin Business

May 29th, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – May 29, 2020) – Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (“PharmaDrug” or the “Company”) has released an overview of their plans to enter the European psilocybin marketplace via the pending closing of the acquisition of Interrobang LTD. currently doing business as Super Smart (herein referred to as “Super Smart”). The Company intends […]

MindMed Adds MDMA to Develop Next-Gen Psychedelic Therapies

May 29th, 2020 - Ryan Allway

MindMed Further Expands R&D Collaboration with University Hospital Basel’s Liechti Lab with Plans To Develop Next-Gen Psychedelic Therapies Combining LSD and MDMA NEW YORK, May 27, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, is now adding the psychedelic compound MDMA to its R&D pipeline. The latest […]

The Canadian Securities Exchange (CSE) & CFN Media Partner on “Psychedelics Virtual Conference”

May 28th, 2020 - Ryan Allway

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced a Free, co-branded, global, live virtual event in partnership with the Canadian Securities Exchange (CSE), Investing in Psychedelics, to be held on June 17, 2020. CFN Media has […]

NewLeaf Brands Agrees to Acquire Mindleap Health Inc., Digital Health Platform to Combine Mood, Emotion and Habit Tracking With Tele-health in the Fight Against Mental Illness

May 21st, 2020 - Ryan Allway

NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company”) is pleased to announce that it has signed a non-binding Letter of Intent (“LOI”) with Mindleap Health Inc. (“Mindleap”), dated May 20, 2020, pursuant to which NewLeaf Brands will acquire, by way of share exchange, 100% of all of the issued […]

Pharmadrug Inc. Plans to Enter the Psychedelic Space with An LOI To Acquire Super Smart and Provides Business Update

May 21st, 2020 - Ryan Allway

05/20/2020 | 10:40am EDT Toronto, Ontario–(Newsfile Corp. – May 20, 2020) – Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (“Pharmadrug” or the “Company”) is pleased to announce that it has entered into a non-binding letter of intent (the “Letter of Intent”) dated May 20, 2020 with Interrobang Ltd. doing business as Super Smart (herein referred to […]

NeonMind Completes Design of Preclinical Psilocybin Psychedelic Mushroom Study

May 18th, 2020 - Ryan Allway

The Yield Growth  Corp. (CSE:BOSS) (OTCQB:BOSQF) (FE:YG3) announces its majority owned subsidiary NeonMind has completed the design of a preclinical study to confirm that psilocybin (found in psychedelic mushrooms)  is an effective treatment for weight loss and food craving.  NeonMind engaged Translational Life Sciences Inc. (“TLS”), a contract research organization,  to design the study.  The […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading